Fed. Circ. Urged Not To Review Venue In $20M Cialis IP Row
A German pharmaceutical company has urged the Federal Circuit not to rehear a panel decision that upheld a $20 million Eastern District of Texas jury verdict that Eli Lilly and Co.'s...To view the full article, register now.
Already a subscriber? Click here to view full article